Загрузка...
KRAS突变的非小细胞肺癌的研究进展
Lung cancer is the leading cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) accounts for 80%-85% of all patients with lung cancer, the majority of patients with lung cancer at the time of diagnosis is in the advanced stage. The development of target therapy based on has c...
Сохранить в:
| Опубликовано в: : | Zhongguo Fei Ai Za Zhi |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
中国肺癌杂志编辑部
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5999922/ https://ncbi.nlm.nih.gov/pubmed/29764594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2018.05.11 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|